US regulator clears Mirum’s oral drug for reducing cholesterol deposits
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.
Cambridge researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as.
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.
HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.
HQ Team February 20, 2025: A joint study by the University College London (UCL) and University College London Hospitals (UCLH) has revealed that.
HQ Times February 19, 2025: A new study has revealed that 28 out of every 100 elderly individuals in India are being prescribed.
HQ Team February 18, 2025: A new study from Florida Atlantic University’s Schmidt College of Medicine reveals a troubling rise in childhood mental,.
HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.
February 18, 2025: Scientists at the Icahn School of Medicine at Mount Sinai have achieved a major breakthrough in brain therapy by developing.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com